aVaxziPenTM is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its proprietary aVaxziPen technologies. aVaxziPen creates and delivers vaccines in needle-free, thermally stable, solid dose format that is applicable across all types of vaccines. aVaxziPen was formerly known as Enesi Pharma. It was founded in 2017 and is based in Oxfordshire, United Kingdom.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.